QL
VNDA icon

Quarry LP’s Vanda Pharmaceuticals VNDA Stock Holding History

Quarry LP’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18K Buy
+193
New +$1.26K ﹤0.01% 1892
2025
Q4 		– Sell
-10,702
Closed -$53.4K – 2657
2025
Q3 		$53.4K Buy
+10,702
New +$49.5K 0.01% 804

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quarry LP's VNDA Position: Q2 2026 in Review

Quarry LP opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 193 shares worth $1.18K. The stake represents ﹤0.01% of the portfolio and ranks #1892 among its holdings. This is a return to the name: Quarry LP previously reported a position in VNDA as recently as Q3 2025.

Quarry LP first reported a position in VNDA in Q3 2025 and has held it in 2 quarters since. The position peaked at $53.4K in Q3 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Quarry LP held 193 shares of Vanda Pharmaceuticals worth $1.18K as of Q2 2026.
  • Vanda Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1892 holding.
  • Quarry LP first reported a position in Vanda Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Quarry LP's Vanda Pharmaceuticals position peaked at $53.4K in Q3 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.